Rheological and in vitro release measurements of manufactured acyclovir 5% creams: confirming sensitivity of the in vitro release

Abstract

Previous evaluation of marketed acyclovir 5% creams using in vitro release testing (IVRT) and its correlation with the qualitative composition confirmed the discriminative characteristics of this methodology. This was in line with the principles of Topical drug Classification System (TCS). For the current research, experimental formulations were designed and prepared by applying controlled changes in manufacturing process, sources of raw materials, and amount of the excipients. The topical semisolids were representative for the four classes of TCS. The outcome of the IVRT and rheological assessments was evaluated in relation with the nature of the change and the functional role of the excipients. The variations in propylene glycol content from 5% to 40% impacted both the in vitro release rates (gradual decrease from 16.23 to 8.97 µg/cm²/min^0.5) and the microstructural characteristics (proportional increase of yield stress from 17.98 to 46.40 Pa). The inert excipients e.g. cetostearyl alcohol or white soft paraffin altered majorly the rheological behavior, as their functionality is mainly related to vehicle properties. IVRT was discriminative for the microstructural differences induced by both categories of excipients according to TCS dichotomy. This simple, reliable, and reproducible test reflected the impact of difference in quantitative composition and characteristics of excipients.

Keywords:

• Acyclovir cream
• in vitro release (IVR)
• qualitative and quantitative composition
• microstructure
• Topical Drug Classification System (TCS)

Acknowledgments

Part of this work was supported by a grant from US Product Quality Research Institute. The authors also acknowledge the useful comments and support of Dr Andreas Abend and Dr Filippos Kesisoglou.

Disclosure statement

The authors report no conflict of interest.